Table 1.
Parameter | Non-diabetic patient | Type 2 diabetic patient | p-value |
---|---|---|---|
Age (years) | 68.0 ± 2.0 | 65.2 ± 2.6 | 0.41 |
Sex | 6 M, 1 F | 6 M, 1 F | n/a |
BMI | 28.3 ± 1.6 | 32.6 ± 2.4 | 0.14 |
HbA1C (%) | 5.4 ± 0.2 | 7.4 ± 0.5 | 0.01* |
HbA1C (mmol/mol) | 36 ± 2 | 58 ± 6 | |
Glucose (mmol/L) | 5.9 ± 0.3 | 8.1 ± 1.6 | 0.20 |
Duration of diabetes (y) | 12.2 ± 2.3 | n/a | n/a |
MAP (mmHg) | 98.4 ± 5.3 | n/a | 0.91 |
Beta blockers | 4/7 | 6/7 | n/a |
ACE inhibitors | 6/7 | 5/7 | n/a |
LVEDV (mL) | 88 ± 12 | 86 ± 8 | 0.89 |
LVESV (mL) | 36 ± 6 | 35 ± 4 | 0.92 |
EF (%) | 60 ± 2 | 60 ± 1 | 0.86 |
E vel (cm/s) | 0.6 ± 0.1 | 0.7 ± 0.1 | 0.56 |
A vel (cm/s) | 0.8 ± 0.1 | 0.9 ± 0.1 | 0.26 |
E/A | 0.9 ± 0.1 | 0.8 ± 0.1 | 0.50 |
Data are expressed ± SEM
M male, F female, HbA1C glycated haemoglobin, MAP mean arterial blood pressure, LVEDV left ventricular end diastolic diameter, LVESV left ventricular end systolic diameter, EF ejection fraction
For all parameters independent t-test, * p < 0.05